Uterine artery embolization for adenomyosis without fibroids

ManDeuk Kim, J. W. Won, D. Y. Lee, C. S. Ahn

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Aim: To evaluate the potential usefulness of transcatheter uterine artery embolization as a treatment for symptomatic adenomyosis in patients without uterine fibroids. Materials and methods: Uterine artery embolization using polyvinyl alcohol particles sized 250-710 mm was performed in 43 patients (mean; 40.3 years, range; 31-52 years) with dysmenorrhoea, menorrhagia, or bulk-related symptoms (pelvic heaviness urinary frequency) due to adenomyosis without fibroids. All patients underwent pre-procedural and 3.5 months (range 1-8 months) follow-up magnetic resonance imaging (MRI) with contrast enhancement. Clinical symptoms were also assessed at the time of MRI before and after embolization. Results: Significant improvement of dysmenorrhoea (95.2%) and menorrhagia (95.0%) was reported in most patients. Contrast-enhanced MRI revealed non-enhancing areas suggesting coagulation necrosis of adenomyosis in 31 patients (72.1%), decreased size without necrosis in 11 patients (25.6%), and no change in one patient (2.3%). The mean volume reduction of the uteri after uterine artery embolization was 32.5% (from 321.7 ± 142.9 to 216.7 ± 130.1 cm3). Conclusion: Transcatheter uterine artery embolization is an effective therapy for the treatment of symptomatic pure adenomyosis, and may be a valuable alternative to hysterectomy.

Original languageEnglish
Pages (from-to)520-526
Number of pages7
JournalClinical Radiology
Volume59
Issue number6
DOIs
Publication statusPublished - 2004 Jan 1

Fingerprint

Uterine Artery Embolization
Adenomyosis
Leiomyoma
Menorrhagia
Dysmenorrhea
Magnetic Resonance Imaging
Necrosis
Polyvinyl Alcohol
Hysterectomy
Uterus
Therapeutics

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Kim, ManDeuk ; Won, J. W. ; Lee, D. Y. ; Ahn, C. S. / Uterine artery embolization for adenomyosis without fibroids. In: Clinical Radiology. 2004 ; Vol. 59, No. 6. pp. 520-526.
@article{ded352ea553648a5892a7b268fd84512,
title = "Uterine artery embolization for adenomyosis without fibroids",
abstract = "Aim: To evaluate the potential usefulness of transcatheter uterine artery embolization as a treatment for symptomatic adenomyosis in patients without uterine fibroids. Materials and methods: Uterine artery embolization using polyvinyl alcohol particles sized 250-710 mm was performed in 43 patients (mean; 40.3 years, range; 31-52 years) with dysmenorrhoea, menorrhagia, or bulk-related symptoms (pelvic heaviness urinary frequency) due to adenomyosis without fibroids. All patients underwent pre-procedural and 3.5 months (range 1-8 months) follow-up magnetic resonance imaging (MRI) with contrast enhancement. Clinical symptoms were also assessed at the time of MRI before and after embolization. Results: Significant improvement of dysmenorrhoea (95.2{\%}) and menorrhagia (95.0{\%}) was reported in most patients. Contrast-enhanced MRI revealed non-enhancing areas suggesting coagulation necrosis of adenomyosis in 31 patients (72.1{\%}), decreased size without necrosis in 11 patients (25.6{\%}), and no change in one patient (2.3{\%}). The mean volume reduction of the uteri after uterine artery embolization was 32.5{\%} (from 321.7 ± 142.9 to 216.7 ± 130.1 cm3). Conclusion: Transcatheter uterine artery embolization is an effective therapy for the treatment of symptomatic pure adenomyosis, and may be a valuable alternative to hysterectomy.",
author = "ManDeuk Kim and Won, {J. W.} and Lee, {D. Y.} and Ahn, {C. S.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.crad.2003.11.018",
language = "English",
volume = "59",
pages = "520--526",
journal = "Clinical Radiology",
issn = "0009-9260",
publisher = "W.B. Saunders Ltd",
number = "6",

}

Uterine artery embolization for adenomyosis without fibroids. / Kim, ManDeuk; Won, J. W.; Lee, D. Y.; Ahn, C. S.

In: Clinical Radiology, Vol. 59, No. 6, 01.01.2004, p. 520-526.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Uterine artery embolization for adenomyosis without fibroids

AU - Kim, ManDeuk

AU - Won, J. W.

AU - Lee, D. Y.

AU - Ahn, C. S.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Aim: To evaluate the potential usefulness of transcatheter uterine artery embolization as a treatment for symptomatic adenomyosis in patients without uterine fibroids. Materials and methods: Uterine artery embolization using polyvinyl alcohol particles sized 250-710 mm was performed in 43 patients (mean; 40.3 years, range; 31-52 years) with dysmenorrhoea, menorrhagia, or bulk-related symptoms (pelvic heaviness urinary frequency) due to adenomyosis without fibroids. All patients underwent pre-procedural and 3.5 months (range 1-8 months) follow-up magnetic resonance imaging (MRI) with contrast enhancement. Clinical symptoms were also assessed at the time of MRI before and after embolization. Results: Significant improvement of dysmenorrhoea (95.2%) and menorrhagia (95.0%) was reported in most patients. Contrast-enhanced MRI revealed non-enhancing areas suggesting coagulation necrosis of adenomyosis in 31 patients (72.1%), decreased size without necrosis in 11 patients (25.6%), and no change in one patient (2.3%). The mean volume reduction of the uteri after uterine artery embolization was 32.5% (from 321.7 ± 142.9 to 216.7 ± 130.1 cm3). Conclusion: Transcatheter uterine artery embolization is an effective therapy for the treatment of symptomatic pure adenomyosis, and may be a valuable alternative to hysterectomy.

AB - Aim: To evaluate the potential usefulness of transcatheter uterine artery embolization as a treatment for symptomatic adenomyosis in patients without uterine fibroids. Materials and methods: Uterine artery embolization using polyvinyl alcohol particles sized 250-710 mm was performed in 43 patients (mean; 40.3 years, range; 31-52 years) with dysmenorrhoea, menorrhagia, or bulk-related symptoms (pelvic heaviness urinary frequency) due to adenomyosis without fibroids. All patients underwent pre-procedural and 3.5 months (range 1-8 months) follow-up magnetic resonance imaging (MRI) with contrast enhancement. Clinical symptoms were also assessed at the time of MRI before and after embolization. Results: Significant improvement of dysmenorrhoea (95.2%) and menorrhagia (95.0%) was reported in most patients. Contrast-enhanced MRI revealed non-enhancing areas suggesting coagulation necrosis of adenomyosis in 31 patients (72.1%), decreased size without necrosis in 11 patients (25.6%), and no change in one patient (2.3%). The mean volume reduction of the uteri after uterine artery embolization was 32.5% (from 321.7 ± 142.9 to 216.7 ± 130.1 cm3). Conclusion: Transcatheter uterine artery embolization is an effective therapy for the treatment of symptomatic pure adenomyosis, and may be a valuable alternative to hysterectomy.

UR - http://www.scopus.com/inward/record.url?scp=2942572882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942572882&partnerID=8YFLogxK

U2 - 10.1016/j.crad.2003.11.018

DO - 10.1016/j.crad.2003.11.018

M3 - Article

VL - 59

SP - 520

EP - 526

JO - Clinical Radiology

JF - Clinical Radiology

SN - 0009-9260

IS - 6

ER -